Медицинский совет (Dec 2016)

Hepatoprotectors in the therapy of some hepatic diseases

  • O. N. Minushkin

DOI
https://doi.org/10.21518/2079-701X-2016-14-52-57
Journal volume & issue
Vol. 0, no. 14
pp. 52 – 57

Abstract

Read online

This article deals with the data on therapy of 130 patients who suffered chronic hepatic diseases (metabolic, viral) and by various reasons received the hepatoprotector and the immune modulator Laenneс. The high effectiveness of patients therapy by steatohepatites (alcoholic and non-alcoholic) was shown. In patients with chronic viral hepatitis B and C, who received antiviral therapy Leannec was used successfully to overcome antiviral therapy resistance, to reduce therapy side effects (high fever, muscular weakness, pancytopenia). Laennec allows overcoming these side effects and anemia therapy resistance in patients who suffered from chronic hepatitis at the hepatic cirrhosis stage.

Keywords